Vol 2, No 3 (2025)

This policy perspective highlights how the 2025 BRICS chairship, under Brazil’s leadership, advanced a collective health agenda rooted in equity, innovation, and solidarity among Global South nations. Through the XV BRICS Health Ministers’ Meeting (Brasília, 17 June 2025), members prioritized cooperation on tuberculosis, regulatory convergence, digital health, and the elimination of socially determined diseases. These efforts reaffirmed health as a strategic pillar for multilateral renewal. Among the major outcomes, the bloc launched the Partnership for the Elimination of Socially Determined Diseases, the Network of National Public Health Institutes, and progress on regulatory harmonization and artificial intelligence and health data governance. Together, these initiatives created operational frameworks to expand access, strengthen research collaboration, and build technological sovereignty. Brazil’s domestic achievements – such as World Health Organization’s 2024 certification of lymphatic filariasis elimination and the nationwide digital transformation through the SUS Digital Program and the National Health Data Network – reflect how national progress can reinforce collective goals. By translating shared political will into practical cooperation, BRICS demonstrates that South–South collaboration can deliver measurable results. These advances position the bloc as a driving force for inclusive global health governance and a model for how emerging economies can advance universal health coverage and health for all on a planetary scale

This article analyzes the evolving health cooperation between Brazil and China as a strategic frontier in South-South collaboration. At a time of global health insecurity and technological inequality, the partnership between these two continental powers offers a transformative alternative to traditional donor-recipient models. The analysis traces a shift from commodity-based trade to a potential alliance in co-innovation, encompassing vaccines, artificial intelligence, biotechnology, and digital health. Brazil’s deep dependency on imported medical inputs and its fragmented industrial base stand in contrast to China’s stateled model of technological scaling and global health outreach. Yet, this asymmetry also reveals opportunities: Brazil’s universal health system, research institutions, and regional leadership can be aligned with China’s production capacity, digital infrastructure, and development finance to build shared technological sovereignty. The paper examines how Brazil’s renewed industrial policy under Lula’s administration opens new pathways for joint research and development, regional pharmaceutical production, and equitable technology transfer. It also confronts persistent challenges – technological imbalances, intellectual property constraints, institutional volatility, and geopolitical pressures aimed at curtailing South-South alignment. A successful partnership, the article argues, must be grounded in transparent governance, mutual benefit, and a commitment to health as a public good. It concludes with a proposal for a decentralized health innovation ecosystem in Brazil, inspired by China’s special economic zones, to overcome the historical concentration of technological power and promote equitable development across the North, Northeast, and Center-West. In doing so, the Brazil–China relationship can become a model for a more just, resilient, and multipolar global health order.

The creation of the BRICS Partnership for the Elimination of Socially Determined Diseases marks a pivotal step in positioning the social determinants of health at the forefront of global public policy and collective action. Socially determined diseases shaped by poverty, inequality, inadequate sanitation, and limited access to services, remain significant public health challenges across BRICS nations. Despite substantial progress in science, technology, and health system strengthening, global targets for disease elimination and reduction remain off track due to persistent financial gaps, fragmented programs, and insufficient multisectoral coordination. In this context, BRICS countries, representing nearly half of the world’s population, are uniquely positioned to drive transformative change by integrating health equity principles into national and international agendas. This manuscript describes the technical and political process that led to the formulation of the BRICS Partnership, culminating in its endorsement at the BRICS Leaders’ Meeting. The Partnership outlines five strategic objectives focused on strengthening resilient health systems, advancing intersectoral action, expanding research and innovation, securing sustainable financing, and aligning global positions to accelerate progress toward disease elimination. The initiative offers a comprehensive framework that addresses both disease-specific challenges and the broader structural drivers of inequity. The BRICS Partnership thus emerges as a global model of how collaboration, scientific advancement, multilateralism, and social justice can converge to accelerate the elimination, control, or reduction of socially determined diseases and promote a healthier, more equitable future.